- Case report
- Open Access
11p Microdeletion including WT1 but not PAX6, presenting with cataract, mental retardation, genital abnormalities and seizures: a case report
Molecular Cytogenetics volume 2, Article number: 6 (2009)
WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities and mental retardation) and Potocki-Shaffer syndrome are rare contiguous gene deletion syndromes caused by deletions of the 11p14-p12 chromosome region.
We present a patient with mental retardation, unilateral cataract, bilateral ptosis, genital abnormalities, seizures and a dysmorphic face. Cytogenetic analysis showed a deletion on 11p that was further characterized using FISH and MLPA analyses. The deletion (11p13-p12) located in the area between the deletions associated with the WAGR and Potocki-Shaffer syndromes had a maximum size of 8.5 Mb and encompasses 44 genes. Deletion of WT1 explains the genital abnormalities observed. As PAX6 was intact the cataract observed cannot be explained by a deletion of this gene. Seizures have been described in Potocki-Shaffer syndrome while mental retardation has been described in both WAGR and Potocki-Shaffer syndrome. Characterization of this patient contributes further to elucidate the function of the genes in the 11p14-p12 chromosome region.
The clinical association of Wilms' tumor, aniridia, genitourinary abnormalities and mental retardation (WAGR) is a contiguous gene deletion syndrome caused by a deletion on the short arm of chromosome 11. The syndrome is caused by haploinsufficiency for the PAX6 gene (causing aniridia) and the WT1 gene (predisposing Wilms' tumor, genital abnormalities and nephropathies). Aniridia is clinically required for the diagnosis . Most WAGR patients are mentally retarded to some extent, and obesity has occasionally been noted, however the genetic causes for these traits have not been elucidated [2–5]. Recently Xu et al hypothesised that the SLC1A2, PRRG4 and BDNF genes might contribute to the abnormal mental development .
Potocki-Shaffer syndrome (PSS) is another gene deletion syndrome caused by a deletion on chromosome 11, but more proximal (11p11.2) than the WAGR deletion. The syndrome is characterized by foramina parietalia permanga, multiple exostoses and in some cases craniofacial dysostosis and mental retardation. Haploinsufficiency for EXT2 and ALX4 explains exostoses and parietal foramina respectively [7–9].
We present here a patient with an 8.5 Mb deletion on chromosome 11 located in the area between the WAGR and PSS deletions (11p13-p12).
A 15-year-old boy was referred to us for cytogenetic studies. He was the first child of unrelated parents. Pregnancy and delivery at term (41 weeks of gestation, birth weight 3220 g and length 50 cm) were normal and uneventful.
The patient is mildly to moderately mentally retarded and attends special school. His face is dysmorphic with a depressed nasal bridge, folded ears (especially on the right side), and a maxillary overbite and bilaterally down slanting eyes with ptosis (figure 1). Further ophthalmologic examination revealed unilateral cataract, astigmatism and myopia (right eye).
In the neonatal period cryptorchidism and hypospadias were noted. Upon surgery the testes were found atrophic as well. Nine years old he began to have seizures that were treated medically. After medication a weight gain from the 75 centile to just beneath the 97 centile (weight-for-height ratio) was noted.
Cytogenetic analyses were performed after obtaining informed consent. Conventional cytogenetic preparations were made from PHA-stimulated peripheral blood. At first a normal male karyotype 46,XY was found, but upon re-examination using R-banding with a quality corresponding to approximately 550 bands an 11p deletion was revealed with some uncertainty. Comparative genomic hybridization (chromosome CGH) showed a 11p13 deletion. Fluorescence in situ hybridization (FISH) analysis was carried out using BACs and fosmid clones (CHORI BACPAC resource http://bacpac.chori.org/order.php). The positions of relevant probes are shown in figure 2. The clones for FISH analysis were labeled with biotin using a nick-translation kit following the manufacturer's protocol (Roche Molecular Biochemicals). The probes were preannealed with Cot1 DNA in hybridization mix, denatured for 5 minutes at 75°C, and added to the denatured chromosomal slides. Hybridization was carried out overnight. Signals were detected using 2–3 rounds of amplification with FITC (fluoresceinisothiocyanate) conjugated avidin and anti-avidin antibodies. The chromosomal slides were counterstained with propidium iodide and DAPI. The chromosomes were viewed using Leica FISH station Q550CW using the DMRXA microscope equipped with appropriate filters. A minimum of 20 metaphases was analyzed. MLPA analysis was performed using the P219 kit from mrc-Holland following manufacturer's instructions. The positions of relevant MLPA probes are shown in figure 2.
FISH analysis using probe B2.1 (WT1, 11p14.1 ) showed deletion of Wilms' tumor-locus while FISH analysis using probe FAT5 (aniridia-locus, PAX6 gene, 11p14.1 ) showed signals from both chromosomes 11 (figure 3). A further mapping of the deletion with FISH analysis using BAC and fosmid clones revealed a deletion of approximately 8.5 Mb. This is the maximum size as it is measured from the distal point of the probe juxtaposed to the distal probe deleted (i.e. BAC clone RP10-83G3 juxtaposed to deleted BAC clone RP1-319D17) to the proximal point of the probe juxtaposed to the proximal probe deleted (i.e. fosmid clone G248P8673G5 juxtaposed to deleted fosmid clone G248P89483C8). Thus the distal breakpoint mapped between position 31,803,008 (BAC clone RP10-83G3 not deleted) and position 31,922,410 (BAC clone RP1-319D17 deleted), while the proximal breakpoint mapped between position 40,199,857 (fosmid clone G248P89483C8 deleted) and position 40,289,835 (fosmid clone G248P8673G5 not deleted) (figure 2).
The patient presented in this work shows mental retardation, unilateral cataract, bilateral ptosis, genital abnormalities, seizures and a dysmorphic face. It is uncertain whether the obesity observed is a side effect of the treatment for seizures or if it is part of the syndrome. The deletion breakpoints were mapped using FISH and MLPA analyses. The distal breakpoint was mapped between the PAX6 and RCN1 genes, while the proximal breakpoint was mapped to lie either within or proximal to the LRRC4C gene (Figure 2). The deletion encompasses a total of 44 genes or open reading frames, including the WT1 gene, which explains the genital abnormalities observed. As PAX6 is left intact the cataract observed cannot be explained by a deletion of this gene. One explanation may be that regulatory elements of PAX6 is deleted as such elements have been demonstrated . Regulatory elements, located 5' to the Pax6 gene important for lens induction have been identified in mouse [12, 13]. These upstream elements were not involved in the deletion in the patient described here, and it is purely speculative that others could exist. Another explanation is that the cataract is due to other genes involved in the deletion or causes unrelated to the deletion.
McGaughran et al. reported a case with a cytogenetic visible 11p deletion (del11(p11.2p14) . This patient exhibited features of both WAGR as well as PSS; developmental delay but no seizures. Bremond-Gignac et al described a further case with 11p deletion encompassing EXT2, ALX4, WT1 and PAX6 genes showing features of both WAGR and PSS . In addition, the patient showed obesity. Recently Xu et al. reported 31 WAGR cases and identified the genes deleted in each case using oligonucleotide array-CGH . Three of these cases had seizures. One patient had an intact PAX6 gene, however, ophthalmologic findings of the patient were not described since the scope of the paper was the mental retardation and autism observed in WAGR patients. Xu et al hypothesizes that SLC1A2 and BDNF contributes to the autism and mental retardation . In the patient presented here the SLC1A2 gene was deleted however the BDNF gene was intact.
Seizures have been described in PSS while mental retardation has been described in both WAGR and PSS. There are no obvious candidate genes for these symptoms, but our patient may help to further delineate phenotype-genotype relations in the area.
Written informed consent was obtained from the parents of the patient for publication with any accompanying images.
Wilms' tumor, Aniridia, Genitourinary abnormalities and mental Retardation
Fluorescence In Situ Hybridization
Multiplex Ligation Dependent Probe Amplification
Comparative Genomic Hybridization
Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M: WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005, 116: 984–988. 10.1542/peds.2004-0467
Tiberio G, Digilio MC, Giannotti A: Obesity and WAGR syndrome. Clin Dysmorphol 2000, 9: 63–64. 10.1097/00019605-200009010-00014
Amor DJ: Morbid obesity and hyperphagia in the WAGR syndrome. Clin Dysmorphol 2002, 11: 73–74. 10.1097/00019605-200201000-00016
Lennon PA, Scott DA, Lonsdorf D, Wargowski DS, Kirkpatrick S, Patel A, Cheung SW: WAGR(O?) syndrome and congenital ptosis caused by an unbalanced t(11;15)(p13;p11.2)dn demonstrating a 7 megabase deletion by FISH. Am J Med Genet A 2006, 140: 1214–1218.
Marlin S, Couet D, Lacombe D, Cessans C, Bonneau D: Obesity: a new feature of WAGR (del 11p) syndrome. Clin Dysmorphol 1994, 3: 255–257. 10.1097/00019605-199407000-00012
Xu S, Han JC, Morales A, Menzie CM, Williams K, Fan YS: Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet Genome Res 2008, 122: 181–187. 10.1159/000172086
Shaffer LG, Hecht JT, Ledbetter DH, Greenberg F: Familial interstitial deletion 11(p11.12p12) associated with parietal foramina, brachymicrocephaly, and mental retardation. Am J Med Genet 1993, 45: 581–583. 10.1002/ajmg.1320450512
Potocki L, Shaffer LG: Interstitial deletion of 11(p11.2p12): a newly described contiguous gene deletion syndrome involving the gene for hereditary multiple exostoses (EXT2). Am J Med Genet 1996, 62: 319–325. Publisher Full Text 10.1002/(SICI)1096-8628(19960329)62:3<319::AID-AJMG22>3.0.CO;2-M
Bartsch O, Wuyts W, Van Hul W, Hecht JT, Meinecke P, Hogue D, Werner W, Zabel B, Hinkel GK, Powell CM, Shaffer LG, Willems PJ: Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. Am J Hum Genet 1996, 58: 734–742.
Fantes JA, Bickmore WA, Fletcher JM, Ballesta F, Hanson IM, van HV: Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization. Am J Hum Genet 1992, 51: 1286–1294.
Kammandel B, Chowdhury K, Stoykova A, Aparicio S, Brenner S, Gruss P: Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity. Dev Biol 1999, 205: 79–97. 10.1006/dbio.1998.9128
Williams SC, Altmann CR, Chow RL, Hemmati-Brivanlou A, Lang RA: A highly conserved lens transcriptional control element from the Pax-6 gene. Mech Dev 1998, 73: 225–229. 10.1016/S0925-4773(98)00057-4
Dimanlig PV, Faber SC, Auerbach W, Makarenkova HP, Lang RA: The upstream ectoderm enhancer in Pax6 has an important role in lens induction. Development 2001, 128: 4415–4424.
McGaughran JM, Ward HB, Evans DG: WAGR syndrome and multiple exostoses in a patient with del(11)(p11.2p14.2). J Med Genet 1995, 32: 823–824. 10.1136/jmg.32.10.823
Bremond-Gignac D, Crolla JA, Copin H, Guichet A, Bonneau D, Taine L, Lacombe D, Baumann C, Benzacken B, Verloes A: Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion. Eur J Hum Genet 2005, 13: 409–413. 10.1038/sj.ejhg.5201358
We wish to thank Winni Pedersen, Kennedy Center, Glostrup, Denmark for technical assistance and the family for their contribution to this study.
The authors declare that they have no competing interests.
GJA reviewed all clinical data and prepared the manuscript. PB and RB contributed clinical information. KG and KBN provided valuable support and supervised the practical work in the laboratory. All authors read and approved final manuscript.